Global Raltegravir Market Growth 2025-2031

October 2025 | 75 pages | ID: G59C697FEC9EN
LP Information

Abstracts

The global Raltegravir market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Raltegravir (RAL), sold under the brand name Isentress, is an antiretroviral medication used, together with other medication, to treat HIV/AIDS.

United States market for Raltegravir is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Raltegravir is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Raltegravir is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Raltegravir players cover Merck & Co., Hetero, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the ?Raltegravir Industry Forecast? looks at past sales and reviews total world Raltegravir sales in 2024, providing a comprehensive analysis by region and market sector of projected Raltegravir sales for 2025 through 2031. With Raltegravir sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Raltegravir industry.

This Insight Report provides a comprehensive analysis of the global Raltegravir landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Raltegravir portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Raltegravir market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Raltegravir and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Raltegravir.

This report presents a comprehensive overview, market shares, and growth opportunities of Raltegravir market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Tablet
• Oral Powder

Segmentation by Application:

• Hospital
• Drug Store
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Merck & Co.
• Hetero

Key Questions Addressed in this Report

What is the 10-year outlook for the global Raltegravir market?
What factors are driving Raltegravir market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Raltegravir market opportunities vary by end market size?
How does Raltegravir break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Raltegravir Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Raltegravir by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Raltegravir by Country/Region, 2020, 2024 & 2031
2.2 Raltegravir Segment by Type
  2.2.1 Tablet
  2.2.2 Oral Powder
2.3 Raltegravir Sales by Type
  2.3.1 Global Raltegravir Sales Market Share by Type (2020-2025)
  2.3.2 Global Raltegravir Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Raltegravir Sale Price by Type (2020-2025)
2.4 Raltegravir Segment by Application
  2.4.1 Hospital
  2.4.2 Drug Store
  2.4.3 Others
2.5 Raltegravir Sales by Application
  2.5.1 Global Raltegravir Sale Market Share by Application (2020-2025)
  2.5.2 Global Raltegravir Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Raltegravir Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Raltegravir Breakdown Data by Company
  3.1.1 Global Raltegravir Annual Sales by Company (2020-2025)
  3.1.2 Global Raltegravir Sales Market Share by Company (2020-2025)
3.2 Global Raltegravir Annual Revenue by Company (2020-2025)
  3.2.1 Global Raltegravir Revenue by Company (2020-2025)
  3.2.2 Global Raltegravir Revenue Market Share by Company (2020-2025)
3.3 Global Raltegravir Sale Price by Company
3.4 Key Manufacturers Raltegravir Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Raltegravir Product Location Distribution
  3.4.2 Players Raltegravir Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR RALTEGRAVIR BY GEOGRAPHIC REGION

4.1 World Historic Raltegravir Market Size by Geographic Region (2020-2025)
  4.1.1 Global Raltegravir Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Raltegravir Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Raltegravir Market Size by Country/Region (2020-2025)
  4.2.1 Global Raltegravir Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Raltegravir Annual Revenue by Country/Region (2020-2025)
4.3 Americas Raltegravir Sales Growth
4.4 APAC Raltegravir Sales Growth
4.5 Europe Raltegravir Sales Growth
4.6 Middle East & Africa Raltegravir Sales Growth

5 AMERICAS

5.1 Americas Raltegravir Sales by Country
  5.1.1 Americas Raltegravir Sales by Country (2020-2025)
  5.1.2 Americas Raltegravir Revenue by Country (2020-2025)
5.2 Americas Raltegravir Sales by Type (2020-2025)
5.3 Americas Raltegravir Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Raltegravir Sales by Region
  6.1.1 APAC Raltegravir Sales by Region (2020-2025)
  6.1.2 APAC Raltegravir Revenue by Region (2020-2025)
6.2 APAC Raltegravir Sales by Type (2020-2025)
6.3 APAC Raltegravir Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Raltegravir by Country
  7.1.1 Europe Raltegravir Sales by Country (2020-2025)
  7.1.2 Europe Raltegravir Revenue by Country (2020-2025)
7.2 Europe Raltegravir Sales by Type (2020-2025)
7.3 Europe Raltegravir Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Raltegravir by Country
  8.1.1 Middle East & Africa Raltegravir Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Raltegravir Revenue by Country (2020-2025)
8.2 Middle East & Africa Raltegravir Sales by Type (2020-2025)
8.3 Middle East & Africa Raltegravir Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Raltegravir
10.3 Manufacturing Process Analysis of Raltegravir
10.4 Industry Chain Structure of Raltegravir

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Raltegravir Distributors
11.3 Raltegravir Customer

12 WORLD FORECAST REVIEW FOR RALTEGRAVIR BY GEOGRAPHIC REGION

12.1 Global Raltegravir Market Size Forecast by Region
  12.1.1 Global Raltegravir Forecast by Region (2026-2031)
  12.1.2 Global Raltegravir Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Raltegravir Forecast by Type (2026-2031)
12.7 Global Raltegravir Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Merck & Co.
  13.1.1 Merck & Co. Company Information
  13.1.2 Merck & Co. Raltegravir Product Portfolios and Specifications
  13.1.3 Merck & Co. Raltegravir Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Merck & Co. Main Business Overview
  13.1.5 Merck & Co. Latest Developments
13.2 Hetero
  13.2.1 Hetero Company Information
  13.2.2 Hetero Raltegravir Product Portfolios and Specifications
  13.2.3 Hetero Raltegravir Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Hetero Main Business Overview
  13.2.5 Hetero Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Raltegravir Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Raltegravir Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players ofTablet
Table 4. Major Players of Oral Powder
Table 5. Global Raltegravir Sales by Type (2020-2025) & (K Units)
Table 6. Global Raltegravir Sales Market Share by Type (2020-2025)
Table 7. Global Raltegravir Revenue by Type (2020-2025) & ($ million)
Table 8. Global Raltegravir Revenue Market Share by Type (2020-2025)
Table 9. Global Raltegravir Sale Price by Type (2020-2025) & (USD/Unit)
Table 10. Global Raltegravir Sale by Application (2020-2025) & (K Units)
Table 11. Global Raltegravir Sale Market Share by Application (2020-2025)
Table 12. Global Raltegravir Revenue by Application (2020-2025) & ($ million)
Table 13. Global Raltegravir Revenue Market Share by Application (2020-2025)
Table 14. Global Raltegravir Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Raltegravir Sales by Company (2020-2025) & (K Units)
Table 16. Global Raltegravir Sales Market Share by Company (2020-2025)
Table 17. Global Raltegravir Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Raltegravir Revenue Market Share by Company (2020-2025)
Table 19. Global Raltegravir Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Raltegravir Producing Area Distribution and Sales Area
Table 21. Players Raltegravir Products Offered
Table 22. Raltegravir Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Raltegravir Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Raltegravir Sales Market Share Geographic Region (2020-2025)
Table 27. Global Raltegravir Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Raltegravir Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Raltegravir Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Raltegravir Sales Market Share by Country/Region (2020-2025)
Table 31. Global Raltegravir Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Raltegravir Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Raltegravir Sales by Country (2020-2025) & (K Units)
Table 34. Americas Raltegravir Sales Market Share by Country (2020-2025)
Table 35. Americas Raltegravir Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Raltegravir Sales by Type (2020-2025) & (K Units)
Table 37. Americas Raltegravir Sales by Application (2020-2025) & (K Units)
Table 38. APAC Raltegravir Sales by Region (2020-2025) & (K Units)
Table 39. APAC Raltegravir Sales Market Share by Region (2020-2025)
Table 40. APAC Raltegravir Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Raltegravir Sales by Type (2020-2025) & (K Units)
Table 42. APAC Raltegravir Sales by Application (2020-2025) & (K Units)
Table 43. Europe Raltegravir Sales by Country (2020-2025) & (K Units)
Table 44. Europe Raltegravir Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Raltegravir Sales by Type (2020-2025) & (K Units)
Table 46. Europe Raltegravir Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Raltegravir Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Raltegravir Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Raltegravir Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Raltegravir Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Raltegravir
Table 52. Key Market Challenges & Risks of Raltegravir
Table 53. Key Industry Trends of Raltegravir
Table 54. Raltegravir Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Raltegravir Distributors List
Table 57. Raltegravir Customer List
Table 58. Global Raltegravir Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Raltegravir Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Raltegravir Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Raltegravir Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Raltegravir Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Raltegravir Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Raltegravir Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Raltegravir Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Raltegravir Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Raltegravir Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Raltegravir Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Raltegravir Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Raltegravir Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Raltegravir Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Merck & Co. Basic Information, Raltegravir Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck & Co. Raltegravir Product Portfolios and Specifications
Table 74. Merck & Co. Raltegravir Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Merck & Co. Main Business
Table 76. Merck & Co. Latest Developments
Table 77. Hetero Basic Information, Raltegravir Manufacturing Base, Sales Area and Its Competitors
Table 78. Hetero Raltegravir Product Portfolios and Specifications
Table 79. Hetero Raltegravir Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Hetero Main Business
Table 81. Hetero Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Raltegravir
Figure 2. Raltegravir Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Raltegravir Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Raltegravir Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Raltegravir Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Raltegravir Sales Market Share by Country/Region (2024)
Figure 10. Raltegravir Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture ofTablet
Figure 12. Product Picture of Oral Powder
Figure 13. Global Raltegravir Sales Market Share by Type in 2025
Figure 14. Global Raltegravir Revenue Market Share by Type (2020-2025)
Figure 15. Raltegravir Consumed in Hospital
Figure 16. Global Raltegravir Market: Hospital (2020-2025) & (K Units)
Figure 17. Raltegravir Consumed in Drug Store
Figure 18. Global Raltegravir Market: Drug Store (2020-2025) & (K Units)
Figure 19. Raltegravir Consumed in Others
Figure 20. Global Raltegravir Market: Others (2020-2025) & (K Units)
Figure 21. Global Raltegravir Sale Market Share by Application (2024)
Figure 22. Global Raltegravir Revenue Market Share by Application in 2025
Figure 23. Raltegravir Sales by Company in 2025 (K Units)
Figure 24. Global Raltegravir Sales Market Share by Company in 2025
Figure 25. Raltegravir Revenue by Company in 2025 ($ millions)
Figure 26. Global Raltegravir Revenue Market Share by Company in 2025
Figure 27. Global Raltegravir Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Raltegravir Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Raltegravir Sales 2020-2025 (K Units)
Figure 30. Americas Raltegravir Revenue 2020-2025 ($ millions)
Figure 31. APAC Raltegravir Sales 2020-2025 (K Units)
Figure 32. APAC Raltegravir Revenue 2020-2025 ($ millions)
Figure 33. Europe Raltegravir Sales 2020-2025 (K Units)
Figure 34. Europe Raltegravir Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Raltegravir Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa Raltegravir Revenue 2020-2025 ($ millions)
Figure 37. Americas Raltegravir Sales Market Share by Country in 2025
Figure 38. Americas Raltegravir Revenue Market Share by Country (2020-2025)
Figure 39. Americas Raltegravir Sales Market Share by Type (2020-2025)
Figure 40. Americas Raltegravir Sales Market Share by Application (2020-2025)
Figure 41. United States Raltegravir Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Raltegravir Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Raltegravir Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Raltegravir Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Raltegravir Sales Market Share by Region in 2025
Figure 46. APAC Raltegravir Revenue Market Share by Region (2020-2025)
Figure 47. APAC Raltegravir Sales Market Share by Type (2020-2025)
Figure 48. APAC Raltegravir Sales Market Share by Application (2020-2025)
Figure 49. China Raltegravir Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Raltegravir Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Raltegravir Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Raltegravir Revenue Growth 2020-2025 ($ millions)
Figure 53. India Raltegravir Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Raltegravir Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Raltegravir Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Raltegravir Sales Market Share by Country in 2025
Figure 57. Europe Raltegravir Revenue Market Share by Country (2020-2025)
Figure 58. Europe Raltegravir Sales Market Share by Type (2020-2025)
Figure 59. Europe Raltegravir Sales Market Share by Application (2020-2025)
Figure 60. Germany Raltegravir Revenue Growth 2020-2025 ($ millions)
Figure 61. France Raltegravir Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Raltegravir Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Raltegravir Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Raltegravir Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Raltegravir Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Raltegravir Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Raltegravir Sales Market Share by Application (2020-2025)
Figure 68. Egypt Raltegravir Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Raltegravir Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Raltegravir Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Raltegravir Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Raltegravir Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Raltegravir in 2025
Figure 74. Manufacturing Process Analysis of Raltegravir
Figure 75. Industry Chain Structure of Raltegravir
Figure 76. Channels of Distribution
Figure 77. Global Raltegravir Sales Market Forecast by Region (2026-2031)
Figure 78. Global Raltegravir Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Raltegravir Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Raltegravir Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Raltegravir Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Raltegravir Revenue Market Share Forecast by Application (2026-2031)